News

Filter by Category

Filter by Program

Filter by Date

February 14, 2023

Regulus Therapeutics Joins PKDOC

C-Path is excited to announce that Regulus Therapeutics, Inc. has joined the Polycystic Kidney Disease Outcomes Consortium (PKD

February 7, 2023

C-Path is excited to announce that Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) has joined its Polycy

January 23, 2023

Critical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By

December 16, 2022

C-Path’s eCOA Consortium and PRO Consortium are pleased to announce the publication of two open access articles in the Jour

November 30, 2022

C-Path’s eCOA Consortium is pleased to announce that “Implementing Numeric Rating and Visual Analog Scales in an eCOA Soluti

November 3, 2022

C-Path’s eCOA Consortium is pleased to announce that “Survey Investigates Backup Solution Adoption for ePRO Systems” has bee

September 29, 2022

C-Path’s eCOA Consortium is pleased to announce that “Evaluating the Use of Backup Solutions for ePRO Systems” has been publ

August 26, 2022

C-Path and PKDOC are excited to announce that four reports summarizing Sessions 1, 2, and 3B from the 2021 PKD Regulatory Summit h

August 5, 2022

C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of chang

July 25, 2022

C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i